Red Blood Cell Folate Likely Overestimated in Australian National Survey: Implications for Neural Tube Defect Risk

In 2009, the Australian government mandated the addition of folic acid to bread flour to reduce the incidence of neural tube defects (NTD)-affected pregnancies. In 2011–2012, the Australian Health Measures Survey (AHMS) reported a mean red blood cell (RBC) folate in women of reproductive age (16–44 y) of 1647 nmol/L. Over 99% of women had an RBC folate ≥ 906 nmol/L, a concentration consistent with a very low risk of NTDs if a woman became pregnant. However, RBC folate was measured using an immunoassay, which is not a recommended method due to questionable accuracy. The microbiological assay is the preferred method for RBC folate measurement. To determine whether the immunoassay method may have led to spurious conclusions about the folate status of Australian women, we collected fasting blood samples from 74 healthy non-pregnant, non-lactating women (18–44 y) and measured RBC folate using both the immunoassay and microbiological methods. Mean RBC folate (95% confidence interval) concentration measured with the immunoassay method was 1735 (1666, 1804) nmol/L compared with 942 (887, 1012) nmol/L using the microbiological method. No woman had an RBC folate < 906 nmol/L using the immunoassay method, whereas 46% of women had an RBC folate < 906 nmol/L using the microbiological method. The NTD risk was estimated to be 0.06% using the immunoassay method and 0.14% using the microbiological method. RBC folate using AHMS survey may have underestimated NTD risk in Australian women.

[1]  M. Sternberg,et al.  Harmonizing the Calibrator and Microorganism Used in the Folate Microbiological Assay Increases the Comparability of Serum and Whole-Blood Folate Results in a CDC Round-Robin Study. , 2018, The Journal of nutrition.

[2]  Greg S Garrett,et al.  A public health approach for preventing neural tube defects: folic acid fortification and beyond , 2018, Annals of the New York Academy of Sciences.

[3]  M. Tremblay,et al.  The direction of the difference between Canadian and American erythrocyte folate concentrations is dependent on the assay method employed: a comparison of the Canadian Health Measures Survey and National Health and Nutrition Examination Survey , 2014, British Journal of Nutrition.

[4]  Paul Henry Golding Severe experimental folate deficiency in a human subject - a longitudinal investigation of red-cell folate immunoassay errors as megaloblastic anaemia develops , 2014, SpringerPlus.

[5]  O. Devine,et al.  Population red blood cell folate concentrations for prevention of neural tube defects: bayesian model , 2014, BMJ : British Medical Journal.

[6]  C. Sempos,et al.  Estimation of trends in serum and RBC folate in the U.S. population from pre- to postfortification using assay-adjusted data from the NHANES 1988-2010. , 2012, The Journal of nutrition.

[7]  C. Pfeiffer,et al.  Folate Analytical Methodology , 2009 .

[8]  F. Stanley,et al.  Trends in neural tube defects in Western Australia in Indigenous and non-Indigenous populations. , 2004, Paediatric and perinatal epidemiology.

[9]  Z. Li,et al.  Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. , 2000, The New England journal of medicine.

[10]  Hong Wang,et al.  Correction: Prevention of Neural-Tube Defects with Folic Acid in China. , 1999, The New England journal of medicine.

[11]  J. Scott,et al.  Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. , 1997, Methods in enzymology.

[12]  D. Weir,et al.  Folate levels and neural tube defects. Implications for prevention. , 1995, JAMA.

[13]  S. O'broin,et al.  Microbiological assay on microtitre plates of folate in serum and red cells. , 1992, Journal of clinical pathology.

[14]  M. Gnant,et al.  Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study , 1991, The Lancet.